Quote:
Originally Posted by JoGarbe
This thread hasn't been active for awhile, but wondering if there are still people being treated with campath / alemtuzumab. I have a local doctor working with the Cleveland Clinic. I was given a link to access campath, but wondering how others have secured this medication.
Current information takes some searching...
https://www.healthline.com/health-ne...-trials-010814 |
Many news sites (
example) reported that Sanofi withdrew Campath from the market in 2012. There are still clinical trials involving alemtuzumab in the recruiting phase (
example), but I don't know the status for its current use with bone marrow failure diseases like severe aplastic anemia. It's telling that the campath.com website is gone.
Sanofi has an
assistance program for patients who have been prescribed Lemtrade, their newer version of alemtuzumab, used to treat multiple sclerosis. Ironically, aplastic anemia is listed as a possible side effect of Lemtrade when used to treat MS.
I suggest trying the Aplastic Anemia & MDS International Foundation's
Patient HelpLine, to see if they have information about this.